Previous close | 7.05 |
Open | 7.05 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 210.00 |
Expiry date | 2025-12-19 |
Day's range | 7.05 - 7.05 |
Contract range | N/A |
Volume | |
Open interest | N/A |
“We believe earnings growth is set for a healthier runway through 2024,” Morgan Stanley’s analysts wrote.
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Get a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.